CLEC1B

Chr 12

C-type lectin domain family 1 member B

Also known as: 1810061I13Rik, CLEC2, PRO1384, QDED721

CLEC1B encodes a C-type lectin-like receptor that serves as a platelet receptor for podoplanin and plays essential roles in blood/lymphatic vessel separation, thrombus formation, and cerebrovascular development during embryogenesis. This gene is extremely intolerant to loss-of-function variants (pLI near 1.0), indicating that complete loss of protein function is likely incompatible with normal development. Mutations in CLEC1B would be expected to cause severe developmental abnormalities affecting the vascular system, though specific human disease associations have not yet been established.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
8
Pubs (1 yr)
36
P/LP submissions
0%
P/LP missense
1.45
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCLEC1B
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
36 unique Pathogenic / Likely Pathogenic· 50 VUS of 95 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.45LOEUF
pLI 0.000
Z-score 0.36
OE 0.89 (0.571.45)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.73Z-score
OE missense 1.18 (1.031.35)
154 obs / 130.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.89 (0.571.45)
00.351.4
Missense OE1.18 (1.031.35)
00.61.4
Synonymous OE1.49
01.21.6
LoF obs/exp: 12 / 13.4Missense obs/exp: 154 / 130.7Syn Z: -2.56
DN
0.7326th %ile
GOF
0.6931th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

95 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic2
VUS50
Likely Benign5
34
Pathogenic
2
Likely Pathogenic
50
VUS
5
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
34
0
34
Likely Pathogenic
0
0
2
0
2
VUS
0
48
2
0
50
Likely Benign
0
5
0
0
5
Benign
0
0
0
0
0
Total05338091

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CLEC1B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 4 full-text resultsSearch PubTator3 ↗